A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal

Critical Care

Volumn 17, Issue 1, 2013, Pages

  Kerebel, Delphine ^a   Joly, Luc Marie ^b   Honnart, Didier ^c   Schmidt, Jeannot ^d   Galanaud, Damien ^e   Negrier, Claude ^f   Kursten, Friedrich ^g   Coriat, Pierre ^e  

^a Military Teaching Hospital Sainte Anne   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f HOSPICES CIVILS DE LYON   (France)

^g Octapharma AG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; PROTHROMBIN COMPLEX;

AGED; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMOSTASIS; HUMAN; HYPERTHERMIA; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL PRESSURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84872110398     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11923     Document Type: Article

References (31)

1. Baglin TP, Keeling DM, Watson HG. Guidelines on oral anticoagulation (warfarin): third edition--2005 update. Br J Haematol 2006, 132:277-285. 10.1111/j.1365-2141.2005.05856.x, 16409292.
2. Schulman S, Beyth RJ, Kearon C, Levine MN. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, (Suppl 6):257S-298S.
3. Salamat A, Seaton J, Watson HG. Impact of introducing guidelines on anticoagulant reversal. Transfus Med 2005, 15:99-105. 10.1111/j.0958-7578.2005.00558.x, 15859975.
4. Robert-Ebadi H, Le Gal G, Righini M. Use of anticoagulants in elderly patients: practical recommendations. Clin Interv Aging 2009, 4:165-177. 2685237, 19503778.
5. Aguilar MI, Hart RG, Kase CS, Freeman WD, Hoeben BJ, Garcia RC, Ansell JE, Mayer SA, Norrving B, Rosand J, Steiner T, Wijdicks EF, Yamaguchi T, Yasaka M. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc 2007, 82:82-92.
6. Freeman WD, Brott TG, Barrett KM, Castillo PR, Deen HG, Czervionke LF, Meschia JF. Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 2004, 79:1495-1500. 10.4065/79.12.1495, 15595332.
7. Baldi G, Altomonte F, Altomonte M, Ghirarduzzi A, Brusasco C, Parodi RC, Ricciardi A, Remollino V, Spisni V, Saporito A, Caiazza A, Musso G, Cervellin G, Lamberti S, Buzzalino M, De Giorgi F, Del Prato C, Golinelli MP, Gai V, Monsu R, Gioffre M, Giovanardi D, Cattaneo S, Frumento F, Caporrella A, Re G, De Iaco F, Bologna G, Nocenti F, Lorenzi C, et al. Intracranial haemorrhage in patients on antithrombotics: clinical presentation and determinants of outcome in a prospective multicentric study in Italian emergency departments. Cerebrovasc Dis 2006, 22:286-293. 10.1159/000094604, 16847397.
8. Zubkov AY, Mandrekar JN, Claassen DO, Manno EM, Wijdicks EF, Rabinstein AA. Predictors of outcome in warfarin-related intracerebral hemorrhage. Arch Neurol 2008, 65:1320-1325. 10.1001/archneur.65.10.1320, 18852345.
9. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004, 63:1059-1064. 10.1212/01.WNL.0000138428.40673.83, 15452298.
10. Hanley JP. Warfarin reversal. J Clin Pathol 2004, 57:1132-1139. 10.1136/jcp.2003.008904, 1770479, 15509671.
11. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, (Suppl 6):160S-198S.
12. Dentali F, Ageno W, Crowther M. Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost 2006, 4:1853-1863. 10.1111/j.1538-7836.2006.01986.x, 16961594.
13. Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 2004, 181:492-497.
14. Morgenstern LB, Hemphill JC, Anderson C, Becker K, Broderick JP, Connolly ES, Greenberg SM, Huang JN, MacDonald RL, Messe SR, Mitchell PH, Selim M, Tamargo RJ. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010, 41:2108-2129. 10.1161/STR.0b013e3181ec611b, 20651276.
15. Steiner T, Kaste M, Forsting M, Mendelow D, Kwiecinski H, Szikora I, Juvela S, Marchel A, Chapot R, Cognard C, Unterberg A, Hacke W. Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 2006, 22:294-316.
16. Ageno W, Garcia D, Aguilar MI, Douketis J, Finazzi G, Imberti D, Iorio A, Key NS, Lim W, Marietta M, Prisco D, Sarode R, Testa S, Tosetto A, Crowther M. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: treatment. Am J Hematol 2009, 84:584-588. 10.1002/ajh.21469, 19610020.
17. Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates. Blood Transfus 2009, 7:325-334. 2782811, 20011645.
18. Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, Svensson PJ, Veenstra DL, Crowther M, Guyatt GH. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, (Suppl 2):e152S-184S.
19. Leissinger CA, Blatt PM, Hoots WK, Ewenstein B. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol 2008, 83:137-143. 10.1002/ajh.21046, 17729241.
20. Bershad EM, Suarez JI. Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature. Neurocrit Care 2010, 12:403-413. 10.1007/s12028-009-9310-0, 19967567.
21. Dentali F, Marchesi C, Pierfranceschi MG, Crowther M, Garcia D, Hylek E, Witt DM, Clark NP, Squizzato A, Imberti D, Ageno W. Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost 2011, 106:429-438. 10.1160/TH11-01-0052, 21800002.
22. Pabinger I, Tiede A, Kalina U, Knaub S, Germann R, Ostermann H. Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal. Ann Hematol 2010, 89:309-316. 10.1007/s00277-009-0830-7, 19787352.
23. Riess HB, Meier-Hellmann A, Motsch J, Elias M, Kursten FW, Dempfle CE. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation. Thromb Res 2007, 121:9-16. 10.1016/j.thromres.2007.02.009, 17407788.
24. Vigue B, Ract C, Tremey B, Engrand N, Leblanc PE, Decaux A, Martin L, Benhamou D. Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage. Intensive Care Med 2007, 33:721-725. 10.1007/s00134-007-0528-z, 17260127.
25. Josic D, Hoffer L, Buchacher A, Schwinn H, Frenzel W, Biesert L, Klocking HP, Hellstern P, Rokicka-Milewska R, Klukowska A. Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity. Thromb Res 2000, 100:433-441. 10.1016/S0049-3848(00)00339-X, 11150587.
26. Yasaka M, Sakata T, Minematsu K, Naritomi H. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Thromb Res 2002, 108:25-30. 10.1016/S0049-3848(02)00402-4, 12586128.
27. Patriquin CJ, Chin-Yee IH, Kovacs MJ, Lazo-Langner A, Keeney M, Hsia C. Study of Octaplex dosing accuracy: an in vitro analysis. Thromb Haemost 2011, 107:248-252. 10.1160/TH11-09-0610, 22186847.
28. Dargaud Y, Desmurs-Clavel H, Marin S, Bordet JC, Poplavsky JL, Negrier C. Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study. J Thromb Haemost 2008, 6:962-968. 10.1111/j.1538-7836.2008.02964.x, 18373620.
29. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, Begtrup K, Steiner T. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006, 66:1175-1181. 10.1212/01.wnl.0000208408.98482.99, 16636233.
30. Kuwashiro T, Yasaka M, Itabashi R, Nakagaki H, Miyashita F, Naritomi H, Minematsu K. Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage. Cerebrovasc Dis 2011, 31:170-176. 10.1159/000321766, 21135553.
31. Menzin J, Hoesche J, Friedman M, Nichols C, Bergman GE, Crowther M, Garcia D, Jones C. Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records. J Thromb Haemost 2012, 10:596-605. 10.1111/j.1538-7836.2012.04636.x, 22257107.